Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study

被引：29

作者：

de la Rubia, Javier ^{[1
,2
]}

Roig, Monica ^{[1
]}

Ibanez, Angela ^{[3
]}

Garcia, Inmaculada ^{[5
]}

Vera, Jose A. ^{[4
]}

Aguilar, Carlos ^{[6
]}

del Campo, Raquel ^{[7
]}

Gonzalez, Nicolas ^{[8
]}

Martinez, Rafael ^{[9
]}

Palomera, Luis ^{[10
]}

Picon, Isabel ^{[11
]}

Rodriguez, Juan N. ^{[12
]}

Sanz, Miguel A. ^{[1
]}

机构：

[1] Hosp La Fe, E-46009 Valencia, Spain

[2] Univ Catolica San Vicente Martir, Valencia, Spain

[3] Gen Hosp, Albacete, Spain

[4] Hosp Virgen Macarena, Seville, Spain

[5] Gen Hosp, Castellon de La Plana, Spain

[6] Hosp Santa Barbara, Soria, Spain

[7] Hosp Son Llatzer, Palma de Mallorca, Spain

[8] Hosp Gen Obispo Polanco, Teruel, Spain

[9] Hosp Clin San Carlos, Madrid, Spain

[10] Hosp Lozano Blesa, Zaragoza, Spain

[11] Inst Valenciano Oncol, Valencia, Spain

[12] Hosp Juan Ramon Jimenez, Huelva, Spain

来源：

EUROPEAN JOURNAL OF HAEMATOLOGY | 2010年 / 85卷 / 04期

关键词：

RENAL-FAILURE; PLUS DEXAMETHASONE; THALIDOMIDE; COMBINATION; THERAPY;

D O I：

10.1111/j.1600-0609.2010.01500.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：363 / 365

页数：3

共 9 条

[1] Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study [J].

Chanan-Khan, Asher A. ;

Kaufman, Jonathan L. ;

Mehta, Jayesh ;

Richardson, Paul G. ;

Miller, Kena C. ;

Lonial, Sagar ;

Munshi, Nikhil C. ;

Schlossman, Robert ;

Tariman, Joseph ;

Singhal, Seema .

BLOOD, 2007, 109 (06) :2604-2606

[2] Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma [J].

Dimopoulos, Meletios ;

Spencer, Andrew ;

Attal, Michael ;

Prince, H. Miles ;

Harousseau, Jean-Luc ;

Dmoszynska, Anna ;

San Miguel, Jesus ;

Hellmann, Andrzej ;

Facon, Thierry ;

Foa, Robin ;

Corso, Alessandro ;

Masliak, Zvenyslava ;

Olesnyckyj, Marta ;

Yu, Zhinuan ;

Patin, John ;

Zeldis, Jerome B. ;

Knight, Robert D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) :2123-2132

[3] Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment [J].

Dimopoulos, Meletios A. ;

Christoulas, Dimitrios ;

Roussou, Maria ;

Kastritis, Efstathios ;

Migkou, Magdalini ;

Gavriatopoulou, Maria ;

Matsouka, Charis ;

Mparmparoussi, Despoina ;

Psimenou, Erasmia ;

Grapsa, Irini ;

Efstathiou, Eleni ;

Terpos, Evangelos .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (01) :1-5

[4] International uniform response criteria for multiple myeloma [J].

Durie, B. G. M. ;

Harousseau, J-L ;

Miguel, J. S. ;

Blade, J. ;

Barlogie, B. ;

Anderson, K. ;

Gertz, M. ;

Dimopoulos, M. ;

Westin, J. ;

Sonneveld, P. ;

Ludwig, H. ;

Gahrton, G. ;

Beksac, M. ;

Crowley, J. ;

Belch, A. ;

Boccadaro, M. ;

Turesson, I. ;

Joshua, D. ;

Vesole, D. ;

Kyle, R. ;

Alexanian, R. ;

Tricot, G. ;

Attal, M. ;

Merlini, G. ;

Powles, R. ;

Richardson, P. ;

Shimizu, K. ;

Tosi, P. ;

Morgan, G. ;

Rajkumar, S. V. .

LEUKEMIA, 2006, 20 (09) :1467-1473

[5] Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia [J].

Harris, E ;

Behrens, J ;

Samson, D ;

Rahemtulla, A ;

Russell, NH ;

Byrne, JL .

BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (01) :160-161

[6] BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma [J].

Niesvizky, Ruben ;

Jayabalan, David S. ;

Christos, Paul J. ;

Furst, Jessica R. ;

Naib, Tara ;

Ely, Scott ;

Jalbrzikowski, Jessica ;

Pearse, Roger N. ;

Zafar, Faiza ;

Pekle, Karen ;

LaRow, April ;

Lent, Richard ;

Mark, Tomer ;

Cho, Hearn J. ;

Shore, Tsiporah ;

Tepler, Jeffrey ;

Harpel, John ;

Schuster, Michael W. ;

Mathew, Susan ;

Leonard, John P. ;

Mazumdar, Madhu ;

Chen-Kiang, Selina ;

Coleman, Morton .

BLOOD, 2008, 111 (03) :1101-1109

[7] Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naive patients undergoing front-line lenalidomide and dexamethasone therapy [J].

Niesvizky, Ruben ;

Naib, Tara ;

Christos, Paul J. ;

Jayabalan, David ;

Furst, Jessica R. ;

Jalbrzikowski, Jessica ;

Zafar, Faiza ;

Mark, Tomer ;

Lent, Richard ;

Pearse, Roger N. ;

Ely, Scott ;

Leonard, John P. ;

Mazumdar, Madhu ;

Chen-Kiang, Selina ;

Coleman, Morton .

BRITISH JOURNAL OF HAEMATOLOGY, 2007, 138 (05) :640-643

[8] Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure [J].

Tosi, P ;

Zamagni, E ;

Cellini, C ;

Cangini, D ;

Tacchetti, P ;

Tura, S ;

Baccarani, M ;

Cavo, M .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (02) :98-103

[9] Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America [J].

Weber, Donna M. ;

Chen, Christine ;

Niesvizky, Ruben ;

Wang, Michael ;

Belch, Andrew ;

Stadtmauer, Edward A. ;

Siegel, David ;

Borrello, Ivan ;

Rajkumar, S. Vincent ;

Chanan-Khan, Asher Alban ;

Lonial, Sagar ;

Yu, Zhinuan ;

Patin, John ;

Olesnyckyj, Marta ;

Zeldis, Jerome B. ;

Knight, Robert D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) :2133-2142

← 1 →